BridgeMD
New treatment option for Achilles Tendon Pain
Official title Progressive Achilles Loading Via Clinician E-support
ClinicalTrials.gov ID: NCT06736795
What this study is testing
- What it's testing
- This is a randomized controlled trial with individuals who have Achilles tendon pain. This study is designed to identify an effective rehabilitation program for Achilles tendon pain that expands access to care for military personnel and to predict treatment response.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Pain localized to the Achilles tendon (insertion or midportion)
- AT pain greater than or equal to 3/10 with tendon-loading exercise
You likely can't join if
- Younger than 18 years of age or older than 60 years of age
- BMI \> 45 kg/m2
- Pain primarily due to a differential diagnosis, including paratendonitis, bursitis (retrocalcaneal or subcutaneous), posterior ankle impingement or...
- Presence of a partial Achilles tendon tear or rupture on imaging or a history of Achilles tendon rupture that was verified by surgical or...
- Attended physical therapy for AT in the past 3 months
- History of steroid injection to lower extremity tendons/fascia, ESWT or any injection to the Achilles tendon region in the past 3 months
See the full eligibility criteria
- Pain localized to the Achilles tendon (insertion or midportion)
- AT pain greater than or equal to 3/10 with tendon-loading exercise
- Younger than 18 years of age or older than 60 years of age
- BMI \> 45 kg/m2
- Pain primarily due to a differential diagnosis, including paratendonitis, bursitis (retrocalcaneal or subcutaneous), posterior ankle impingement or os trigonum, irritation or neuropathy of the sural nerve, plantaris...
- Presence of a partial Achilles tendon tear or rupture on imaging or a history of Achilles tendon rupture that was verified by surgical or conservative management
- Attended physical therapy for AT in the past 3 months
- History of steroid injection to lower extremity tendons/fascia, ESWT or any injection to the Achilles tendon region in the past 3 months
- History of taking fluoroquinolones in the past 6 months
- History of surgery or invasive procedure for AT on side enrolling for treatment
- Diagnosed systemic conditions affecting the foot and ankle (e.g., rheumatoid arthritis, ankylosing spondylitis), endocrine disorder with complications (e.g., uncontrolled Type I or II diabetes, diabetic peripheral...
- At high risk for falls (four step square test \>15 seconds)
- Refusal of randomization or unable or uninterested in completing virtual visits with a webcam or smart phone or completing quizzes and surveys
The study team makes the final eligibility decision.
Where it's taking place
- Iowa City, Iowa, United States
- Fort Cavazos, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Iowa City, Iowa, United States; Fort Cavazos, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.